Tyler Jacks
Directeur/Membre du Conseil chez THERMO FISHER SCIENTIFIC
Fortune : 9 M $ au 30/04/2024
Profil
Tyler E.
Jacks is the founder of T2 Biosystems, Inc. (founded in 2006) and Dragonfly Therapeutics, Inc. (founded in 2016).
He currently holds positions as an Independent Director at Amgen, Inc. (since 2012), Director at Thermo Fisher Scientific, Inc. (since 2009), President & Director at Commonwealth Cancer Consortium, Inc. (since 2021), and Professor at Massachusetts Institute of Technology (since 2007).
Dr. Jacks previously served as Chairman at the National Cancer Institute and as Director at the David H.
Koch Institute for Integrative Cancer Research (from 2007 to 2021).
He received his undergraduate degree from Harvard University in 1983 and his doctorate degree from The University of California, San Francisco in 1988.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 22/05/2024 | 8 398 ( 0,00% ) | 5 M $ | 30/04/2024 | |
AMGEN INC.
0,00% | 31/05/2024 | 16 005 ( 0,00% ) | 4 M $ | 30/04/2024 |
Postes actifs de Tyler Jacks
| Sociétés | Poste | Début |
|---|---|---|
| THERMO FISHER SCIENTIFIC | Directeur/Membre du Conseil | 26/05/2009 |
| AMGEN INC. | Directeur/Membre du Conseil | 01/01/2012 |
| Massachusetts Institute of Technology | Corporate Officer/Principal | 01/01/2007 |
| Commonwealth Cancer Consortium, Inc. | President | 01/02/2021 |
Anciens postes connus de Tyler Jacks
| Sociétés | Poste | Fin |
|---|---|---|
David H. Koch Institute for Integrative Cancer Research
 David H. Koch Institute for Integrative Cancer Research Miscellaneous Commercial ServicesCommercial Services David H. Koch Institute for Integrative Cancer Research operates a research facility for cancer cure development. The company was founded in 2007 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | 01/01/2021 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Président | 01/01/2016 |
| T2 BIOSYSTEMS, INC. | Fondateur | 01/01/2013 |
Dragonfly Therapeutics, Inc.
 Dragonfly Therapeutics, Inc. BiotechnologyHealth Technology Dragonfly Therapeutics, Inc. develops therapy to stimulate immune responses against cancer. The company was founded by Tyler Jacks, Bill Haney and David Raulet in 2015 and is headquartered in Waltham, MA. | Fondateur | - |
Formation de Tyler Jacks
| Harvard University | Undergraduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| T2 BIOSYSTEMS, INC. | Health Technology |
| THERMO FISHER SCIENTIFIC | Health Technology |
| AMGEN INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
David H. Koch Institute for Integrative Cancer Research
David H. Koch Institute for Integrative Cancer Research Miscellaneous Commercial ServicesCommercial Services David H. Koch Institute for Integrative Cancer Research operates a research facility for cancer cure development. The company was founded in 2007 and is headquartered in Cambridge, MA. | Commercial Services |
Dragonfly Therapeutics, Inc.
Dragonfly Therapeutics, Inc. BiotechnologyHealth Technology Dragonfly Therapeutics, Inc. develops therapy to stimulate immune responses against cancer. The company was founded by Tyler Jacks, Bill Haney and David Raulet in 2015 and is headquartered in Waltham, MA. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
| Commonwealth Cancer Consortium, Inc. |
